Skip to content
Disclosery

Aventail Capital Group, LP: EMR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Aventail Capital Group, LP on EMR, newest first. How the timeline and the estimate are built.

Aventail Capital Group, LP held 0 EMR shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 0 shares
    Change vs previous 13F -53,784 shares

    13F-HR 0001420506-26-001817 filed by Aventail Capital Group, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2026-03-31
    13F 53,784 shares
    Change vs previous 13F -3,826 shares

    0.34% of the 13F portfolio, value $7,046,780.

    13F-HR 0001420506-26-001162 filed by Aventail Capital Group, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 57,610 shares
    Change vs previous 13F -19,313 shares

    0.44% of the 13F portfolio, value $7,645,999.

    13F-HR 0001420506-26-000562 filed by Aventail Capital Group, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 76,923 shares
    Change vs previous 13F not available

    0.48% of the 13F portfolio, value $10,090,759.

    13F-HR 0001420506-25-003409 filed by Aventail Capital Group, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).